日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma

核受体RORγ刺激的肿瘤线粒体氧化磷酸化是骨肉瘤的一种有效治疗契机。

Jianwei Zheng ,Qianqian Wang ,Jianghe Chen ,Guodi Cai ,Zhenhua Zhang ,Hongye Zou ,June X Zou ,Qianqian Liu ,Shufeng Ji ,Guoli Shao ,Hong Li ,Sheng Li ,Hong-Wu Chen ,LinLin Lu ,Yanqiu Yuan ,Peiqing Liu ,Junjian Wang

RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype

RORγ是癌症亚型中胆固醇生物合成的可靶向主调节剂

Demin Cai, Junjian Wang, Bei Gao, Jin Li, Feng Wu, June X Zou, Jianzhen Xu, Yuqian Jiang, Hongye Zou, Zenghong Huang, Alexander D Borowsky, Richard J Bold, Primo N Lara, Jian Jian Li, Xinbin Chen, Kit S Lam, Ka-Fai To, Hsing-Jien Kung, Oliver Fiehn, Ruqian Zhao, Ronald M Evans, Hong-Wu Chen

KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC

KDM8/JMJD5 作为 AR 和 PKM2 的双重共激活因子,整合了 AR/EZH2 网络和 CRPC 中的肿瘤代谢。

Wang, Hung-Jung; Pochampalli, Mamata; Wang, Ling-Yu; Zou, June X; Li, Pei-Shan; Hsu, Sheng-Chieh; Wang, Bi-Juan; Huang, Shih-Han; Yang, Ping; Yang, Joy C; Chu, Cheng-Ying; Hsieh, Chia-Ling; Sung, Shian-Ying; Li, Chien-Feng; Tepper, Clifford G; Ann, David K; Gao, Allen C; Evans, Christopher P; Izumiya, Yoshihiro; Chuu, Chi-Pin; Wang, Wen-Ching; Chen, Hong-Wu; Kung, Hsing-Jien

Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling

组蛋白甲基转移酶 NSD2 通过刺激 ADAM9-EGFR-AKT 信号传导介导三阴性乳腺癌细胞的存活和侵袭

Jun-Jian Wang, June X Zou, Hong Wang, Zhi-Jian Duan, Hai-Bin Wang, Peng Chen, Pei-Qing Liu, Jian-Zhen Xu, Hong-Wu Chen

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

ROR-γ 驱动雄激素受体表达并代表去势抵抗性前列腺癌的治疗靶点

Junjian Wang, June X Zou, Xiaoqian Xue, Demin Cai, Yan Zhang, Zhijian Duan, Qiuping Xiang, Joy C Yang, Maggie C Louie, Alexander D Borowsky, Allen C Gao, Christopher P Evans, Kit S Lam, Jianzhen Xu, Hsing-Jien Kung, Ronald M Evans, Yong Xu, Hong-Wu Chen

Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy

沉默表观遗传沉默子 KDM4A 以实现 TRAIL 和 DR5 同时诱导和抗肿瘤治疗

Junjian Wang, Haibin Wang, Ling-Yu Wang, Demin Cai, Zhijian Duan, Yanhong Zhang, Peng Chen, June X Zou, Jianzhen Xu, Xinbin Chen, Hsing-Jien Kung, Hong-Wu Chen

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

组蛋白甲基转移酶 NSD2 重编程代谢通过协调激活戊糖磷酸途径酶来驱动内分泌抵抗

Junjian Wang, Zhijian Duan, Zoann Nugent, June X Zou, Alexander D Borowsky, Yanhong Zhang, Clifford G Tepper, Jian Jian Li, Oliver Fiehn, Jianzhen Xu, Hsing-Jien Kung, Leigh C Murphy, Hong-Wu Chen

CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance

CDK1 介导的 SIRT3 激活增强线粒体功能和肿瘤放射抗性

Rui Liu, Ming Fan, Demet Candas, Lili Qin, Xiaodi Zhang, Angela Eldridge, June X Zou, Tieqiao Zhang, Shuaib Juma, Cuihong Jin, Robert F Li, Julian Perks, Lun-Quan Sun, Andrew T M Vaughan, Chun-Xu Hai, David R Gius, Jian Jian Li

Transporting Cells in Semi-Solid Gel Condition and at Ambient Temperature

在半固体凝胶条件下和室温下运输细胞

Wang, Junjian; Chen, Peng; Xu, Jianzhen; Zou, June X; Wang, Haibin; Chen, Hong-Wu

ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma

ATAD2 过表达与 B-MYB 翻译特征的丰富和侵袭性子宫内膜癌的发展相关

Camilla Krakstad, Ingvild L Tangen, Erling A Hoivik, Mari K Halle, Anna Berg, Henrica M Werner, Maria B Ræder, Kanthida Kusonmano, June X Zou, Anne M Øyan, Ingunn Stefansson, Jone Trovik, Karl-Henning Kalland, Hong-Wu Chen, Helga B Salvesen